Oncology Associates of Oregon Willamette Valley Cancer Center — Eugene, Oregon

Oncology Associates of Oregon Willamette Valley Cancer Center is a clinical research site located in Eugene, Oregon, United States 97401.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Oncology Associates of Oregon Willamette Valley Cancer Center has participated in 6 clinical trials with 5 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, B-cell Malignancies, CLL.

Sponsors: BeOne Medicines, BeiGene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Eugene

Browse all research sites in Oregon · View every site in Eugene

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Associates of Oregon Willamette Valley Cancer Center?

Oncology Associates of Oregon Willamette Valley Cancer Center has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Associates of Oregon Willamette Valley Cancer Center conducted?

Oncology Associates of Oregon Willamette Valley Cancer Center has 6 clinical trials on record, with 5 currently active. Their work covers Chronic Lymphocytic Leukemia, B-cell Malignancies, CLL.

Is Oncology Associates of Oregon Willamette Valley Cancer Center accredited by Crixeo Clinical Trials?

Oncology Associates of Oregon Willamette Valley Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology Associates of Oregon Willamette Valley Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.